Matulac, Rogelio B.

HRN: 22-02-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/01/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/01/2022
11/07/2022
IVT
600mg
Q8
Sacral Ulcer
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: